Despite the heavy influx of capital over the past years, medtech or biopharma sell-side assignments can still be ripe with challenges. In this episode of Back Bay’s industry podcast, Back Bay Life Science Advisors’ investment banking team discuss best practices for successful sell-side licensing, partnering, and M&A, including: 
Best practices for readying vital aspects of deal preparation 
Identifying deal issues, red flags ahead of time
Articulation of the path forward, including indication and proof of concept and telling the story through to market
The importance of choosing the right partner and alignment for stakeholders, management, board, investors, internal champions and others
The most significant mistakes made in competitive intelligence, technology, position, IP regulatory strategies
Networking, contacts and how to know who’s going to be responsible for what and when
Make sure to subscribe to The Life Science Report podcast and follow Back Bay Life Science Advisors on LinkedIn. Thank you for joining us.